Investment in Joint Venture (Investee Losses in Excess of Investment) (Details Narrative) - USD ($) |
3 Months Ended | 26 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2020 |
Mar. 31, 2019 |
Mar. 31, 2020 |
Dec. 31, 2019 |
|
Net loss | $ (2,264,086) | $ (3,110,527) | ||
Framatome [Member] | ||||
Investment in Enfission | $ 2,900,000 | |||
Enfission LLC [Member] | ||||
Total contributions | 9,200,000 | 9,200,000 | ||
Research and Development cost | 1,300,000 | 1,300,000 | $ 1,300,000 | |
Net loss | 100,000 | $ 2,000,000 | ||
Cash | 200,000 | 200,000 | ||
Total receivables due amount | $ 0 | $ 0 | $ 400,000 | |
Enfission LLC [Member] | Joint Venture Operating Agreement [Member] | ||||
Percentage of Class A voting membership | 50.00% | 50.00% |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|